
Why we're working together
Why we're working together
All life needs water. It’s the world’s most precious resource, necessary to make many essential products we use in our daily lives, including medicines, and the energy we use daily. Freshwater habitats—such as lakes, rivers, streams, wetlands, and aquifers— contain more than 10% of all known animals and around 50% of all known fish species.
Meanwhile, freshwater wildlife populations have suffered the harshest decline in size of all monitored wildlife populations, seeing an 85% decrease since 1970, according to WWF’s latest Living Planet Report.

Despite how important water is for people and nature, it is a surprisingly finite resource. Less than 1% of the world's water is fresh and accessible.
The world’s freshwater resources are increasingly under stress, posing a threat to the health of local communities and the resilience of businesses who rely on freshwater as part of manufacturing processes.
Together, WWF and GSK will work together to accelerate the delivery of GSK’s nature commitments with a focus on protecting and restoring freshwater ecosystems, both within GSK’s operations and in its supply chain, as well as demonstrating best practice for the pharmaceutical industry.

At WWF, we know we cannot achieve this level of change alone. We need to mobilise communities, businesses and government to act and feel empowered. GSK is a leader in the pharmaceutical sector and is committed to a net-zero, nature-positive and healthier planet.
GSK is one of the first companies to adopt a verified, science-based target for nature and has developed ambitious freshwater targets covering water stewardship, water use and manufacturing emissions, including being water neutral in its own operations and at key suppliers in water-stressed regions by 2030.
By working with WWF, GSK will support global freshwater initiatives, in alignment with global efforts to protect 30% of oceans, lands, and freshwaters by 2030, including the Freshwater Challenge, which aims to restore 300,000km of degraded rivers and 350 million hectares of degraded wetlands by 2030.
Freshwater is fundamental to human health and the production of medicines and vaccines.
As an industry so dependent on water it’s critical that the pharmaceutical sector takes action in tackling the climate and nature emergency.
